Live Breaking News & Updates on Serum institute ceo

Stay informed with the latest breaking news from Serum institute ceo on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Serum institute ceo and stay connected to the pulse of your community

Serum Institute CEO Adar Poonawalla expects malaria vaccine supply-demand mismatch to end in 2024

"We're expecting a final WHO approval in the coming months, after which we can roll it out," Poonawalla told Reuters in an interview, adding that the company had already produced more than 20 million doses of product in anticipation of the clearance.

India , Kozhikode , Kerala , Adar-poonawalla , Healthcare-management-analytics-programme , Offering-college , Serum-institute-of-india , Reuters , Indian-school-of-business , Britain-university-of-oxford , Serum-institute , World-health-organization-on

COVID-19 vaccine: Delhi govt urges Serum Institute to 'come to rescue' after it runs out of Covaxin

Besides asking the Adar Poonawalla-backed pharma behemoth to come to its rescue, the Delhi government's letter mentioned that vaccination centres will have to be shut down due to the non-availability of vaccines

Delhi , India , Bharat , Monika-rana , Narendra-modi , Adar-poonawalla , Manish-sisodia , Arvind-kejriwal , Serum-institute , Serum-institute-of-india , Pune-based-serum-institute , Hyderabad-based-bharat-biotech

How profitable is Adar Poonawalla's Serum Institute?

How profitable is Adar Poonawalla's Serum Institute?
At Rs 300, the expected earnings from, let's say, 500 million doses of Covishield stand at about Rs 15,000 crore, which is near three times the total revenue of Serum Institute in FY20
Adar Poonawalla poses with first consignment of Covishield (Photo credit: Twitter)
Vaccine-maker Serum Institute of India has become a household name as Indians scramble to book vaccine slots amid a devastating second wave of coronavirus. While Serum is one of the world's biggest vaccine manufacturers, its name made it to common parlance with the breakout of COVID-19 -- and there is proof to show for it. According to corporate database Capitaline there are 418 Indian companies that posted revenues above Rs 5,000 crore in 2019-20. Out of those, Serum earned the maximum net profit for every rupee of revenue.

Mumbai , Maharashtra , India , Pune , Bharat , Cyrus-poonawalla , Poonawalla-group , Pfizer-inc , Serum-institute , Serum-institute-of-india , Vaccine-maker-serum-institute , Adar-poonawalla-helmed

Pune: Fire breaks out at Serum Institute of India

Updated Jan 21, 2021 · 07:53 pm
Smoke billows out of a Serum Institute of India plant in Pune on Thursday.
|
PTI
Five people died on Thursday after a major fire broke out at Serum Institute of India plant in Pune’s Manjari area, ANI reported. The company has been engaged in large-scale manufacturing of the coronavirus vaccine, Covishield, developed by Oxford University and pharmaceutical firm AstraZeneca.
“Four people were evacuated from the building but when it came under control, five bodies were found by our jawans,” Pune Mayor Murlidhar Mohol said. “The five people who died, were perhaps the workers at the under-construction building.”

Hadapsar , Maharashtra , India , Pune , Serum-institute , Serum-institute-of-india , Serum-institute-ceo , Serum-institute-fire , Coronavirus-vaccine-serum-institute , Coronavirus-vaccine , Coronavirus-news